Keyphrases
Phthalates
100%
Reproductive Development
100%
Female Reproductive
100%
Antenatal Exposure
100%
Polycystic Ovary Syndrome
80%
Mono(2-ethylhexyl) Phthalate
60%
Sex Hormone-binding Globulin
40%
Phthalate Metabolites
40%
Testosterone
20%
Week of Gestation
20%
Maternal Serum
20%
Ultrasound
20%
Dehydroepiandrosterone Sulfate (DHEAS)
20%
Low Prevalence
20%
Inhibin B
20%
Di-(2-ethylhexyl) Phthalate
20%
Antiandrogen
20%
Oestrogenic
20%
Age at Menarche
20%
Early Menarche
20%
Phthalate Exposure
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Uterine Volume
20%
Early Follicular Phase
20%
Negative Association
20%
Adolescent Girls
20%
Negatively Associated
20%
Androstenedione
20%
Reproductive Effects
20%
Pregnancy Cohort
20%
Solid-phase Extraction
20%
Anti-Müllerian Hormone
20%
Octyl
20%
Deconjugation
20%
Maternal Androgens
20%
Raine Study
20%
Serum anti-Müllerian Hormone
20%
Medicine and Dentistry
Phthalic Acid
100%
Metabolite
27%
Polycystic Ovarian Syndrome
27%
Sex Hormone Binding Globulin
18%
Menarche
18%
Liquid Chromatography-Mass Spectrometry
18%
Muellerian Inhibiting Factor
18%
Pregnancy
9%
Maternal Serum
9%
Prevalence
9%
Androgen
9%
Inhibin B
9%
Phthalic Acid Bis(2 Ethylhexyl) Ester
9%
Follicular Phase
9%
Androstenedione
9%
Tandem Mass Spectrometry
9%
Pharmacology, Toxicology and Pharmaceutical Science
Phthalic Acid
100%
Syndrome
27%
Sex Hormone Binding Globulin
18%
Muellerian Inhibiting Factor
18%
Prevalence
9%
Androgen
9%
Phthalic Acid Bis(2 Ethylhexyl) Ester
9%
Inhibin B
9%
Androstenedione
9%